The Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma
This pilot clinical trial studies the correlation between the genetics and brain images of patients with newly diagnosed glioblastoma before surgery. The genetic characteristics of a tumor are an important way to predict how well it will respond to treatment. Imaging, using magnetic resonance imaging (MRI), takes detailed pictures of organs inside the body, and may also provide information that helps doctors predict how brain tumors will respond to treatment. If MRI can provide doctors with similar information about the tumor as the tumor's genes, it may be able to be used to predict tumor response in patients whose tumors cannot be reached by surgery or biopsy to get tissue samples.
• Patients who will be undergoing surgery for newly-diagnosed glioblastoma
• Subtotal, gross total or biopsy patients will be eligible
• Confirmation of pathology as glioblastoma